Section 11839.2.  


Latest version.
  • The following controlled substances are authorized for use in narcotic replacement therapy by licensed narcotic treatment programs:

    (a) Methadone.

    (b) Levoalphacetylmethadol (LAAM) as specified in paragraph (10) of subdivision (c) of Section 11055.

    (c) Buprenorphine products or combination of products approved by the federal Food and Drug Administration for maintenance or detoxification of opioid dependence.

    (d) Any other federally approved, controlled substances used for the purpose of narcotic replacement treatment.

(Amended by Stats. 2013, Ch. 22, Sec. 48. Effective June 27, 2013. Operative July 1, 2013, by Sec. 110 of Ch. 22.)